MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehlert, F. J.
Right arrow Articles by Rathbun, B. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehlert, F. J.
Right arrow Articles by Rathbun, B. E.

Signaling through the muscarinic receptor-adenylate cyclase system of the heart is buffered against GTP over a range of concentrations

FJ Ehlert and BE Rathbun

Department of Pharmacology, College of Medicine, University of California, Irvine 92717.

The influence of GTP on muscarinic receptor occupancy and inhibition of adenylate cyclase activity was investigated in well washed homogenates of the rat myocardium. In these homogenates, the highly efficacious muscarinic agonist oxotremorine-M was without effect on adenylate cyclase activity in the absence of exogenous GTP but caused a maximal 38% inhibition of the enzyme in the presence of 0.1 microM GTP. Increasing the concentration of GTP to 0.1 mM caused small to moderate increases in the maximal inhibition of adenylate cyclase elicited by oxotremorine-M and in the concentration of this agonist required for half-maximal inhibition of the enzyme. In contrast, the same change in the concentration of GTP (0.1 microM to 0.1 mM) caused a relatively large increase (46-fold) in the concentration of oxotremorine-M necessary for half-maximal receptor occupancy. Similar observations were made for the highly efficacious muscarinic agonist carbachol. Our results show that GTP increases receptor coupling efficiency and decreases agonist affinity and that these two effects oppose one another, so that the level of muscarinic agonist-mediated inhibition of adenylate cyclase activity remains relatively constant over a range of concentrations of GTP. We have also used a model to predict the influence of GTP on receptor binding properties and agonist-mediated inhibition of adenylate cyclase activity and have calculated theoretical results generally consistent with the experimental observations.

Volume 38, Issue 1, pp. 148-158, 07/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
M. T. Griffin, K. W. Figueroa, S. Liller, and F. J. Ehlert
Estimation of Agonist Activity at G Protein-Coupled Receptors: Analysis of M2 Muscarinic Receptor Signaling through Gi/o,Gs, and G15
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1193 - 1207.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. R. Price, G. L. Baillie, A. Thomas, L. A. Stevenson, M. Easson, R. Goodwin, A. McLean, L. McIntosh, G. Goodwin, G. Walker, et al.
Allosteric Modulation of the Cannabinoid CB1 Receptor
Mol. Pharmacol., November 1, 2005; 68(5): 1484 - 1495.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. A. Wreggett and J. W. Wells
Cooperativity Manifest in the Binding Properties of Purified Cardiac Muscarinic Receptors
J. Biol. Chem., September 22, 1995; 270(38): 22488 - 22499.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics